You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股异动|药品股普涨丽珠医药(1513.HK)升近4%领涨
格隆汇 08-22 09:55
格隆汇8月22日丨药品股普涨,丽珠医药(1513.HK)升近4%领涨,三生制药、康哲药业涨逾3%,石药集团、中生制药、中国中药涨逾2%,药明康德、复星医药等涨逾1%。个股方面,石药集团昨晚发公告称,新型靶点抗肿瘤药物“SYHA1801”获临床许可。复星医药公告指就分拆复宏汉霖上市将仅向合资格复星医药H股股东提供保证配额。业绩上,丽珠医药中期归母净利润同比增长16.67%;石药集团中期纯利同比增24.8%,暂6日连升累涨逾28%。白云山今日将发财报,国药控股明日发财报。板块方面,国家医保药品常规准入目录昨日挂网发布,医保局初步确定将128个药品纳入拟谈判准入范围。有分析人士指,一方面更多药品纳入目录,药企收入自然增加,但另一方面降费或令盈利减少,因此投资者买卖医药股时需评估相关风险。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account